one of the advantages Pharma has is that they have large libraries of compounds that they can use for screening potential therapeutic targets. Once a research lab publishes a finding, its in the public domain and fair game for further development.
Comments
Log in with your Bluesky account to leave a comment
Yep, and charge thousands of times more than cost. Development is a false equivalency. Universities don’t advertise. Pharmaceuticals spend more on sales advertising than research
But only for narrow profit. Universities have these libraries too and they are in most cases available to companies to sponsor research. Strange that people see strength as a weakness. People fail to see the interdependencies of our world-leading research ecosystem. Pharma & unis are complementary.
I’ve built some very complicated and expensive screening systems in both academic labs and pharma, but my budgets look pretty paltry compared to the cost of a clinical trial.
Comments
That’s where the co-operation ends and obscene profits begin….
Cutting at the wrong end